Archives of Clinical Infectious Diseases

Published by: Kowsar

Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran

Ali Karimi 1 , Reza Imani-Rastabi 2 , Masoumeh Moezzi 3 and Mohammad-Taghi Moradi 4 , *
Authors Information
1 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
2 Department of Infectious and Tropical Diseases, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
3 Department of Community Medicine, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
4 Student’s Research Committee, Medical Plants Research Center, Shahrekord University of Medical Science, Shahrekord, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: January 1, 2016, 11 (1); e32288
  • Published Online: January 23, 2016
  • Article Type: Research Article
  • Received: September 5, 2015
  • Revised: December 9, 2015
  • Accepted: December 15, 2015
  • DOI: 10.5812/archcid.32288

To Cite: Karimi A, Imani-Rastabi R, Moezzi M, Moradi M. Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran, Arch Clin Infect Dis. 2016 ; 11(1):e32288. doi: 10.5812/archcid.32288.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001; 14(1): 38-58[DOI][PubMed]
  • 2. Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012; 4(3): 68-73[DOI][PubMed]
  • 3. Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985; 313(17): 1059-67[DOI][PubMed]
  • 4. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004; 132(6): 1005-22[PubMed]
  • 5. Saneian H, Rahimi H, Shoaei P. Hepatitis A Seropositivity among First-Year Students of the Medical University in Isfahan, Iran. Int J Prev Med. 2014; 5-12[PubMed]
  • 6. Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016; 144(2): 291-6[DOI][PubMed]
  • 7. Hollinger FB, Ticehurst JR. Fields Virology 1996; : 735-82
  • 8. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005; 34(3): 600-9[DOI][PubMed]
  • 9. Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006; 28: 101-11[DOI][PubMed]
  • 10. Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi MA. Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran. Jundishapur J Microbiol. 2015; 8(7)[DOI][PubMed]
  • 11. Hayajneh WA, Balbeesi A, Faouri S. Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children. J Med Virol. 2015; 87(4): 569-74[DOI][PubMed]
  • 12. Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 1996; 98(6 Pt 1): 1207-15[PubMed]
  • 13. Advisory Committee on Immunization P, Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006; 55: 1-23[PubMed]
  • 14. Sung JJ. Epidemiology of hepatitis A in Asia and experience with the HAV vaccine in Hong Kong. J Viral Hepat. 2000; 7 Suppl 1: 27-8[PubMed]
  • 15. Sofian M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Azad-Armaki S, et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010; 8(3): 176-9[DOI][PubMed]
  • 16. Abdolvahab M, Behnaz K, Sima B, M T. Hepatitis a in young adults in the golestan province, northeast of iran. J Glob Infect Dis. 2010; 2(2): 198-9[DOI][PubMed]
  • 17. Taghavi Ardakani A, Soltani B, Sehat M, Namjoo S, Haji Rezaei M. Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in kashan-iran. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 18. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008; 29(3): 160-2[PubMed]
  • 19. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011; 11(4): 285-8[PubMed]
  • 20. Kazemi A, Mahram M, Koosha A, Amirmoghaddami SHR. Seroprevalence of Hepatitis A in 7-10 year-old children. Iran J Pediatr. 2007; 17(1): 47-51
  • 21. Elikaei A, Sharifi Z, Shooshtari MM, Hosseini M, Maroufi Y. Prevalence of HAV among healthy blood donors referring to Tehran transfusion center. Iran J Public Health. 2008; 37(4): 126-30
  • 22. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004; 19(3): 275-8[PubMed]
  • 23. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2): 99-104[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments